Literature DB >> 22023150

Time for clinical trials of epigenetic drugs in psychiatric disorders?

Jacob Peedicayil, Aniket Kumar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22023150      PMCID： PMC3269591          DOI： 10.1111/j.1365-2125.2011.04100.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  9 in total

1.  Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder.

Authors:  Hamid Mostafavi Abdolmaleky; Kuang-Hung Cheng; Stephen V Faraone; Marsha Wilcox; Stephen J Glatt; Fangming Gao; Cassandra L Smith; Rahim Shafa; Batol Aeali; Julie Carnevale; Hongjie Pan; Panagiotis Papageorgis; Jose F Ponte; Vadivelu Sivaraman; Ming T Tsuang; Sam Thiagalingam
Journal:  Hum Mol Genet       Date:  2006-09-19       Impact factor: 6.150

Review 2.  Epigenetics and complex disease: from etiology to new therapeutics.

Authors:  Carolyn Ptak; Arturas Petronis
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

3.  Genetics in psychiatry: are the promises met?

Authors:  Brigitta Bondy
Journal:  World J Biol Psychiatry       Date:  2011-03       Impact factor: 4.132

4.  Vanishing clinical psychopharmacology.

Authors:  Joop van Gerven; Adam Cohen
Journal:  Br J Clin Pharmacol       Date:  2011-07       Impact factor: 4.335

5.  DNA methyltransferase inhibitors coordinately induce expression of the human reelin and glutamic acid decarboxylase 67 genes.

Authors:  Marija Kundakovic; Ying Chen; Erminio Costa; Dennis R Grayson
Journal:  Mol Pharmacol       Date:  2006-10-25       Impact factor: 4.436

Review 6.  Epigenetic therapy--a new development in pharmacology.

Authors:  Jacob Peedicayil
Journal:  Indian J Med Res       Date:  2006-01       Impact factor: 2.375

7.  Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice.

Authors:  Lucio Tremolizzo; Mohemed-Salim Doueiri; Erbo Dong; Dennis R Grayson; John Davis; Graziano Pinna; Patricia Tueting; Virginia Rodriguez-Menendez; Erminio Costa; Alessandro Guidotti
Journal:  Biol Psychiatry       Date:  2005-03-01       Impact factor: 13.382

8.  Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder.

Authors:  Hamid Mostafavi Abdolmaleky; Sahab Yaqubi; Panagiotis Papageorgis; Arthur W Lambert; Sait Ozturk; Vadivelu Sivaraman; Sam Thiagalingam
Journal:  Schizophr Res       Date:  2011-05-07       Impact factor: 4.939

Review 9.  The role of epigenetics in mental disorders.

Authors:  Jacob Peedicayil
Journal:  Indian J Med Res       Date:  2007-08       Impact factor: 2.375
  9 in total
  2 in total

1.  Antidepressant-like effect of sodium butyrate is associated with an increase in TET1 and in 5-hydroxymethylation levels in the Bdnf gene.

Authors:  Yabin Wei; Philippe A Melas; Gregers Wegener; Aleksander A Mathé; Catharina Lavebratt
Journal:  Int J Neuropsychopharmacol       Date:  2014-10-31       Impact factor: 5.176

Review 2.  Epigenetic mechanisms in migraine: a promising avenue?

Authors:  Else Eising; Nicole A Datson; Arn M J M van den Maagdenberg; Michel D Ferrari
Journal:  BMC Med       Date:  2013-02-04       Impact factor: 8.775
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.